1. Ancrod versus heparin for anticoagulation during vascular surgical procedures 
C.William Cole, MD, FRCS a, Janis Bormanis, MD, FRCPC b, Gregory K. Luna a, MD, George Hajjar, MD, FRCSC a, Graeme G. Barber, MD, FRCSC a, Kenneth A. Harris, MD, FRCSC a, William F. Brien, MD, FRCPC b 
Journal of Vascular Surgery 
Volume 17, Issue 2, Pages (February 1993)
DOI: / (93)90414-H
Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

2. Fig. 1
Schematic representation of thrombin (left) and ancrod (right) and their proteolytic actions on fibrinogen and factor XIII (FSF). Ancrod cleaves A-fibrinopeptides but not fibrinopeptide-B from fibrinogen. In the chromatographic assay of fibrinopeptide fragments, letters (e.g., AY) used to described peptides of different molecular weight or polymerized (AP) fragments.
Journal of Vascular Surgery  , DOI: ( / (93)90414-H)
Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions